What are FGFR1 inhibitor drugs?

FGFR1 inhibitor drugs are pharmacologic agents that share a common mechanism (typically targeting FGFR1 (Fibroblast Growth Factor Receptor 1)). 0 are currently marketed, with 3 more in clinical development.

FGFR1 inhibitor

0 marketed 3 in Phase 3

This page covers all FGFR1 inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting FGFR1 (Fibroblast Growth Factor Receptor 1), FGFR1.

Targets

FGFR1 (Fibroblast Growth Factor Receptor 1) · FGFR1

Phase 3 pipeline (3)

ABT-712 · AbbVie (prior sponsor, Abbott) · Oncology
ABT-712 is a selective inhibitor of fibroblast growth factor receptor 1 (FGFR1) that blocks aberrant signaling in cells dependent on FGFR1 activation.
AZD5335 · AstraZeneca · Oncology
AZD5335 is a selective inhibitor of fibroblast growth factor receptor 1 (FGFR1) that blocks aberrant FGFR signaling in cancer cells.
AZD0120 · AstraZeneca · Oncology
AZD0120 is a selective inhibitor of fibroblast growth factor receptor 1 (FGFR1) that blocks aberrant signaling in cancer cells dependent on FGFR1 activation.